These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12237594)

  • 1. Treatment of cerebrospinal fluid shunt infections: a decision analysis.
    Schreffler RT; Schreffler AJ; Wittler RR
    Pediatr Infect Dis J; 2002 Jul; 21(7):632-6. PubMed ID: 12237594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid shunt infections in children.
    Turgut M; Alabaz D; Erbey F; Kocabas E; Erman T; Alhan E; Aksaray N
    Pediatr Neurosurg; 2005; 41(3):131-6. PubMed ID: 15995329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF shunt infections: a fifteen-year experience with emphasis on management and outcome.
    Morissette I; Gourdeau M; Francoeur J
    Can J Neurol Sci; 1993 May; 20(2):118-22. PubMed ID: 8334572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized study of therapy in cerebrospinal fluid shunt infection.
    James HE; Walsh JW; Wilson HD; Connor JD; Bean JR; Tibbs PA
    Neurosurgery; 1980 Nov; 7(5):459-63. PubMed ID: 7003434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
    James HE; Bradley JS
    Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
    Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection.
    Tamber MS; Klimo P; Mazzola CA; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():60-71. PubMed ID: 25988784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.
    Simon TD; Kronman MP; Whitlock KB; Gove NE; Mayer-Hamblett N; Browd SR; Cochrane DD; Holubkov R; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes WJ; Riva-Cambrin J; Rozzelle C; Shannon C; Tamber M; Wellons JC; Whitehead WE; Kestle JRW
    J Neurosurg Pediatr; 2018 Apr; 21(4):346-358. PubMed ID: 29393813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections of central nervous system shunts.
    Gardner P; Leipzig T; Phillips P
    Med Clin North Am; 1985 Mar; 69(2):297-314. PubMed ID: 3990436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endoscopic third ventriculostomy at infected cerebrospinal fluid shunt removal.
    Shimizu T; Luciano MG; Fukuhara T
    J Neurosurg Pediatr; 2012 Mar; 9(3):320-6. PubMed ID: 22380962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of shunt infections: a multicenter pilot study.
    Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
    J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection risk for Bactiseal Universal Shunts versus Chhabra shunts in Ugandan infants: a randomized controlled trial.
    Mbabazi-Kabachelor E; Shah M; Vaughan KA; Mugamba J; Ssenyonga P; Onen J; Nalule E; Kapur K; Warf BC
    J Neurosurg Pediatr; 2019 Mar; 23(3):397-406. PubMed ID: 30611153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites.
    Winston KR; Ho JT; Dolan SA
    J Neurosurg Pediatr; 2013 Jun; 11(6):635-42. PubMed ID: 23601015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
    Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
    J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid shunt infections in children.
    Ronan A; Hogg GG; Klug GL
    Pediatr Infect Dis J; 1995 Sep; 14(9):782-6. PubMed ID: 8559628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and management of internal cerebrospinal fluid shunt infections.
    Dawod J; Tager A; Darouiche RO; Al Mohajer M
    J Hosp Infect; 2016 Aug; 93(4):323-8. PubMed ID: 27107616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.